The Optimal Width of Gastric Conduit for Minimally Invasive Esophagectomy: Wide or Narrow?
NCT ID: NCT01696682
Last Updated: 2013-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2012-09-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study of Laparoscopic Proximal Gastrectomy Based on PTST(Parachute-tunnel- Style Technique) Esophagogastric Anastomose.
NCT06217991
The Effect of Perioperative Hyperglycemia on Anastomotic Leaks After Total Gastrectomy
NCT07140991
Clinical Trial of Reconstruction After Proximal Gastrectomy
NCT05418920
Comparison of Channel Esophagogastrostomy and Double Tract Reconstruction After Laparoscopic-assist Proximal Gastrectomy: a Propensity Score-Matched Analysis
NCT06741124
Laparoscopic Sleeve Gastrectomy: a Cohort Study
NCT03629808
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Narrow Gastric Conduit
The group in which narrowed gastric conduit will be performed during minimally invasive esophagectomy
Narrowed Gastric Conduit
The gastric conduit will be formed much narrower in the intervention arm during minimally invasive esophagectomy
Wide Gastric Conduit
The group in which widened gastric conduit will be performed during minimally invasive esophagectomy
Widened Gastric Conduit
A widened gastric tube will be formed during the surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Narrowed Gastric Conduit
The gastric conduit will be formed much narrower in the intervention arm during minimally invasive esophagectomy
Widened Gastric Conduit
A widened gastric tube will be formed during the surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Clinical Staged T1-3N0M0 esophageal cancer patients or: patients who were restaged as T1-3N0M0 esophageal cancer after neo-adjuvant therapy
Exclusion Criteria
2. Severe Co-morbidity
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tan, Lijie
Associate Professor of Surgery; Vice Chief, Division of Thoracic Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lijie Tan, MD
Role: STUDY_DIRECTOR
Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Thoracic Surgery, Zhongshan Hospital of Fudan University
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZSchest2012001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.